2022年EASL非酒精性脂肪性肝病(NAFLD)峰会

欧洲肝脏研究协会(EASL)成立于1966年，是欧洲最大的肝病研究组织，在世界各地拥有4500多名会员。自成立以来，EASL已从一个小型组织逐渐发展成为一个具有重要影响力的国际组织宣，其使命是促进肝脏病学的研究；为医生和科学家提供最先进的教育；促进公众对肝脏疾病及其管理的认识，让所有参与肝病研究的人都可以发挥他们的最佳潜力，成为肝病方面的专家，治愈和预防肝病。

NAFLD Summit theme will be Metabolism, alcohol and toxicity. NAFLD is the leading cause of chronic liver disease, not only in Western countries but also amongst many other developed and developing countries. At EASL, we are committed to helping clinicians, researchers and students network with various stakeholders in the field of hepatology, providing the opportunity to share research and learn from peers across Europe and beyond.